# A Study of the Clinical Benefit of Tobramycin Inhalation Solution

> **NCT06106789** · — · ACTIVE_NOT_RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 1600 (estimated)

## Conditions studied

- Bronchiectasis
- Cystic Fibrosis
- Lung Infection

## Interventions

- **DRUG:** Tobramycin inhalation solution

## Key facts

- **NCT ID:** NCT06106789
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06106789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06106789, "A Study of the Clinical Benefit of Tobramycin Inhalation Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06106789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*